Compare SGMT & MYFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SGMT | MYFW |
|---|---|---|
| Founded | 2006 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Major Banks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.2M | 244.6M |
| IPO Year | 2023 | 2018 |
| Metric | SGMT | MYFW |
|---|---|---|
| Price | $5.21 | $25.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $27.00 | $24.25 |
| AVG Volume (30 Days) | ★ 800.4K | 26.7K |
| Earning Date | 03-11-2026 | 01-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 391.62 |
| EPS | N/A | ★ 1.28 |
| Revenue | N/A | ★ $95,514,000.00 |
| Revenue This Year | N/A | $15.96 |
| Revenue Next Year | $125.00 | $13.23 |
| P/E Ratio | ★ N/A | $20.32 |
| Revenue Growth | N/A | ★ 19.92 |
| 52 Week Low | $1.73 | $17.52 |
| 52 Week High | $11.41 | $28.00 |
| Indicator | SGMT | MYFW |
|---|---|---|
| Relative Strength Index (RSI) | 39.15 | 47.65 |
| Support Level | $5.31 | $24.75 |
| Resistance Level | $5.74 | $26.58 |
| Average True Range (ATR) | 0.52 | 0.95 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 8.70 | 63.55 |
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.